Astrana Health, Inc.
ASTH
$29.19
-$0.64-2.15%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 60.66% | -43.35% | -13.15% | -72.25% | -87.16% |
| Total Other Revenue | 34.57% | 54.41% | 90.30% | 40.70% | 44.37% |
| Total Revenue | 34.66% | 53.43% | 88.43% | 37.49% | 39.65% |
| Cost of Revenue | 39.74% | 66.18% | 95.74% | 47.15% | 40.95% |
| Gross Profit | 6.14% | -3.55% | 29.50% | 0.95% | 32.76% |
| SG&A Expenses | 41.09% | 9.73% | 9.71% | 28.54% | 49.46% |
| Depreciation & Amortization | -7.22% | 34.40% | 65.77% | 68.73% | 75.16% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.08% | 59.91% | 86.18% | 45.68% | 42.04% |
| Operating Income | -32.35% | -27.04% | 118.60% | -27.27% | 11.24% |
| Income Before Tax | -47.25% | -59.99% | -305.09% | -29.47% | 1.29% |
| Income Tax Expenses | -34.11% | -52.63% | 477.80% | -22.02% | -28.40% |
| Earnings from Continuing Operations | -53.28% | -63.11% | -8,173.40% | -32.15% | 25.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 70.58% | 123.24% | -93.37% | 51.18% | 37.50% |
| Net Income | -50.85% | -54.89% | -156.26% | -27.04% | 45.57% |
| EBIT | -32.35% | -27.04% | 118.60% | -27.27% | 11.24% |
| EBITDA | -27.37% | -18.15% | 757.17% | -17.74% | 19.91% |
| EPS Basic | -52.41% | -56.01% | -157.69% | -28.78% | 42.11% |
| Normalized Basic EPS | -45.70% | -41.42% | -94.60% | -30.10% | 13.98% |
| EPS Diluted | -52.50% | -55.45% | -158.09% | -29.79% | 42.86% |
| Normalized Diluted EPS | -45.58% | -41.34% | -94.60% | -30.35% | 13.81% |
| Average Basic Shares Outstanding | 3.30% | 2.56% | -2.49% | 2.45% | 2.44% |
| Average Diluted Shares Outstanding | 3.11% | 2.41% | -2.49% | 2.78% | 2.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |